Sommaire

• • ·Call for Papers

    Page :I

    

• Review

  • ·Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit

    Page :1355-1359

    Srikumar Mallick

    Résumé Résumé Plan Plan

• Original Articles

  • ·A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma

    Page :1360-1370

    B. Ställberg, T. Ekström, F. Neij, P. Olsson, B.-E. Skoogh, G. Wennergren, C.-G. Löfdahl, for the SHARE trial group

    Résumé Résumé Plan Plan  
  • ·Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: An open-label study

    Page :1371-1378

    R. Niven, K.F. Chung, Z. Panahloo, M. Blogg, G. Ayre

    Résumé Résumé Plan Plan  
  • ·Utility of cough response during hypertonic histamine challenge in diagnosing asthma

    Page :1379-1384

    Minna Purokivi, Heikki O. Koskela, Tiina Koistinen, Jarkko Magga, Keijo Peuhkurinen, Vesa Kiviniemi, Kirsi M. Kontra

    Résumé Résumé Plan Plan  
  • ·Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide

    Page :1385-1391

    Marcelo B. Menezes, Antônio L. Teixeira, João Terra Filho, Elcio O. Vianna

    Résumé Résumé Plan Plan  
  • ·ANCA-associated lung fibrosis: Analysis of 17 patients

    Page :1392-1398

    Guillaume Foulon, Philippe Delaval, Dominique Valeyre, Benoît Wallaert, Marie-Pierre Debray, Michel Brauner, Pascale Nicaise, Jacques Cadranel, Vincent Cottin, Abdellatif Tazi, Michel Aubier, Bruno Crestani

    Résumé Résumé Plan Plan  
  • ·Airway inflammation in obstructive sleep apnea: Is leptin the missing link?

    Page :1399-1405

    Sofia Antonopoulou, Stelios Loukides, Georgios Papatheodorou, Charis Roussos, Manos Alchanatis

    Résumé Résumé Plan Plan  
  • ·Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler

    Page :1406-1411

    O. Zetterström, R. Dahl, A. Lindqvist, P. Olsson

    Résumé Résumé Plan Plan  
  • ·Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea

    Page :1412-1416

    Akira Tamura, Yoshiyuki Kawano, Toru Watanabe, Junichi Kadota

    Résumé Résumé Plan Plan  
  • ·Feasibility and interpretation of FE_NO measurements in asthma patients in general practice

    Page :1417-1424

    O. Torre, D. Olivieri, P.J. Barnes, S.A. Kharitonov

    Résumé Résumé Plan Plan  
  • ·Use of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPD

    Page :1425-1430

    Mario Cazzola, Gian Luca Biscione, Franco Pasqua, Girolmina Crigna, Massimiliano Appodia, Vittorio Cardaci, Luigi Ferri

    Résumé Résumé Plan Plan  
  • ·Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension

    Page :1431-1438

    Michael Zlupko, Michael O. Harhay, Robert Gallop, Jennifer Shin, Chris Archer-Chicko, Rajesh Patel, Harold I. Palevsky, Darren B. Taichman

    Résumé Résumé Plan Plan   
  • ·Educational impact of pulmonary rehabilitation: Lung Information Needs Questionnaire

    Page :1439-1445

    Rupert C.M. Jones, Xu Wang, Sam Harding, Julia Bott, Michael Hyland

    Résumé Résumé Plan Plan  
  • ·Persistence of asthma medication use in preschool children

    Page :1446-1451

    Mira G. Zuidgeest, Henriëtte A. Smit, Madelon Bracke, Alet H. Wijga, Bert Brunekreef, Maarten O. Hoekstra, Jorrit Gerritsen, Marjan Kerkhof, Johan C. de Jongste, Hubert G. Leufkens, The PIAMA-Study Group

    Résumé Résumé Plan Plan  
  • ·Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough

    Page :1452-1459

    Suguru Sato, Junpei Saito, Yasuko Sato, Taeko Ishii, Wang Xintao, Yoshinori Tanino, Takashi Ishida, Mitsuru Munakata

    Résumé Résumé Plan Plan  
  • ·Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer

    Page :1460-1467

    Heidi B. Rolke, Per S. Bakke, Frode. Gallefoss

    Résumé Résumé Plan Plan  
  • ·Long-term mortality follow-up of the ISOLDE participants: Causes of death during 13 years after trial completion

    Page :1468-1472

    Geraldine Bale, Pablo Martínez-Camblor, P. Sherwood Burge, Joan B. Soriano

    Résumé Résumé Plan Plan  
  • ·The course of persistent airflow limitation in subjects with and without asthma

    Page :1473-1482

    Stefano Guerra, Duane L. Sherrill, Margaret Kurzius-Spencer, Claire Venker, Marilyn Halonen, Stuart F. Quan, Fernando D. Martinez

    Résumé Résumé Plan Plan   
  • ·Asthma and allergy: Short texts and recommendations of the expert conference of the French Speaking Pneumology Society (SPLF), in partnership with the French Society of Allergology and Clinical Immunology (SFAIC), the French Society of Occupational Medicine (SFMT) and the “Asthma–Allergy” association

    Page :1483-1493

    Isabelle Tillie-Leblond, Antoine Magnan, Gabrielle Pauli, Daniel Vervloet, Benoît Wallaert, Alain Didier, Jacques Ameille, Philippe Godard

    Résumé Résumé Plan Plan

• Short Communication

  • ·Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis

    Page :1494-1496

    G.A. Anwar, S.C. Bourke, G. Afolabi, P. Middleton, C. Ward, R.M. Rutherford

    Résumé Résumé Plan Plan

• Letters to the Editor

  • ·Cough and transdermal long-acting β₂ agonist in Japan

    Page :1497

    Satoru Ebihara, Takae Ebihara, Hiroyuki Arai

    
  • ·Response to S. Ebihara “Cough and transdermal long-acting β2 agonist in Japan”

    Page :1498

    Gen Tamura, Ken Ohta